BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 36293074)

  • 21. Effects of the cysteinyl leukotriene receptor antagonists pranlukast and zafirlukast on tracheal mucus secretion in ovalbumin-sensitized guinea-pigs in vitro.
    Liu YC; Khawaja AM; Rogers DF
    Br J Pharmacol; 1998 Jun; 124(3):563-71. PubMed ID: 9647482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Self-promoted Albumin-Based Nanoparticles for Combination Therapy against Metastatic Breast Cancer via a Hyperthermia-Induced "Platelet Bridge".
    Zhao W; Li T; Long Y; Guo R; Sheng Q; Lu Z; Li M; Li J; Zang S; Zhang Z; He Q
    ACS Appl Mater Interfaces; 2021 Jun; 13(22):25701-25714. PubMed ID: 34041901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CXCL17-derived CD11b
    Hsu YL; Yen MC; Chang WA; Tsai PH; Pan YC; Liao SH; Kuo PL
    Breast Cancer Res; 2019 Feb; 21(1):23. PubMed ID: 30755260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Schisandrin B attenuates cancer invasion and metastasis via inhibiting epithelial-mesenchymal transition.
    Liu Z; Zhang B; Liu K; Ding Z; Hu X
    PLoS One; 2012; 7(7):e40480. PubMed ID: 22848381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Zafirlukast prevented ox-LDL-induced formation of foam cells.
    Song Q; Hu Z; Xie X; Cai H
    Toxicol Appl Pharmacol; 2020 Dec; 409():115295. PubMed ID: 33096109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting lysophosphatidic acid receptor type 1 with Debio 0719 inhibits spontaneous metastasis dissemination of breast cancer cells independently of cell proliferation and angiogenesis.
    David M; Ribeiro J; Descotes F; Serre CM; Barbier M; Murone M; Clézardin P; Peyruchaud O
    Int J Oncol; 2012 Apr; 40(4):1133-41. PubMed ID: 22200658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting the Transforming Growth Factor-beta pathway inhibits human basal-like breast cancer metastasis.
    Ganapathy V; Ge R; Grazioli A; Xie W; Banach-Petrosky W; Kang Y; Lonning S; McPherson J; Yingling JM; Biswas S; Mundy GR; Reiss M
    Mol Cancer; 2010 May; 9():122. PubMed ID: 20504320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neutralization of leukotriene C4 and D4 activity by monoclonal and single-chain antibodies.
    Kawakami Y; Hirano S; Kinoshita M; Otsuki A; Suzuki-Yamamoto T; Suzuki M; Kimoto M; Sasabe S; Fukushima M; Kishimoto K; Izumi T; Oga T; Narumiya S; Sugahara M; Miyano M; Yamamoto S; Takahashi Y
    Biochim Biophys Acta; 2014 Jun; 1840(6):1625-33. PubMed ID: 24361619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leukotriene D4 and prostaglandin E2 signals synergize and potentiate vascular inflammation in a mast cell-dependent manner through cysteinyl leukotriene receptor 1 and E-prostanoid receptor 3.
    Kondeti V; Al-Azzam N; Duah E; Thodeti CK; Boyce JA; Paruchuri S
    J Allergy Clin Immunol; 2016 Jan; 137(1):289-298. PubMed ID: 26255103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lung function improvement in smokers suffering from COPD with zafirlukast, a CysLT(1)-receptor antagonist.
    Cazzola M; Boveri B; Carlucci P; Santus P; DiMarco F; Centanni S; Allegra L
    Pulm Pharmacol Ther; 2000; 13(6):301-5. PubMed ID: 11061985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathophysiology of the cysteinyl leukotrienes and effects of leukotriene receptor antagonists in asthma.
    Bisgaard H
    Allergy; 2001; 56 Suppl 66():7-11. PubMed ID: 11421935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of a cysteinyl leukotriene receptor antagonist on experimental emphysema and asthma combined with emphysema.
    Ikeda G; Miyahara N; Koga H; Fuchimoto Y; Waseda K; Kurimoto E; Taniguchi A; Tanimoto Y; Kataoka M; Tanimoto M; Kanehiro A
    Am J Respir Cell Mol Biol; 2014 Jan; 50(1):18-29. PubMed ID: 23937413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endogenous osteonectin/SPARC/BM-40 expression inhibits MDA-MB-231 breast cancer cell metastasis.
    Koblinski JE; Kaplan-Singer BR; VanOsdol SJ; Wu M; Engbring JA; Wang S; Goldsmith CM; Piper JT; Vostal JG; Harms JF; Welch DR; Kleinman HK
    Cancer Res; 2005 Aug; 65(16):7370-7. PubMed ID: 16103089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preventive effect of genetic knockdown and pharmacological blockade of CysLT
    Chen F; Ghosh A; Wu F; Tang S; Hu M; Sun H; Kong L; Hong H
    Brain Behav Immun; 2017 Feb; 60():255-269. PubMed ID: 27810377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Up-regulation of cysteinyl leukotriene 1 receptor by IL-13 enables human lung fibroblasts to respond to leukotriene C4 and produce eotaxin.
    Chibana K; Ishii Y; Asakura T; Fukuda T
    J Immunol; 2003 Apr; 170(8):4290-5. PubMed ID: 12682264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of cysteinyl leukotrienes in nociceptive and inflammatory conditions in experimental animals.
    Jain NK; Kulkarni SK; Singh A
    Eur J Pharmacol; 2001 Jun; 423(1):85-92. PubMed ID: 11438310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cysteinyl leukotriene receptor 1 (CysLT1R) antagonist montelukast suppresses matrix metalloproteinase-13 expression induced by lipopolysaccharide.
    Wei J; Chen S; Huang C; Guo W; Yang S; Feng B; Chu J
    Int Immunopharmacol; 2018 Feb; 55():193-197. PubMed ID: 29268191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of cysteinyl leukotriene receptor 1 in Aβ1-42-induced neurotoxicity in vitro and in vivo.
    Tang SS; Hong H; Chen L; Mei ZL; Ji MJ; Xiang GQ; Li N; Ji H
    Neurobiol Aging; 2014 Mar; 35(3):590-9. PubMed ID: 24269024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure-based mechanism of cysteinyl leukotriene receptor inhibition by antiasthmatic drugs.
    Luginina A; Gusach A; Marin E; Mishin A; Brouillette R; Popov P; Shiriaeva A; Besserer-Offroy É; Longpré JM; Lyapina E; Ishchenko A; Patel N; Polovinkin V; Safronova N; Bogorodskiy A; Edelweiss E; Hu H; Weierstall U; Liu W; Batyuk A; Gordeliy V; Han GW; Sarret P; Katritch V; Borshchevskiy V; Cherezov V
    Sci Adv; 2019 Oct; 5(10):eaax2518. PubMed ID: 31633023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction of platelet-derived autotaxin with tumor integrin αVβ3 controls metastasis of breast cancer cells to bone.
    Leblanc R; Lee SC; David M; Bordet JC; Norman DD; Patil R; Miller D; Sahay D; Ribeiro J; Clézardin P; Tigyi GJ; Peyruchaud O
    Blood; 2014 Nov; 124(20):3141-50. PubMed ID: 25277122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.